dr. usmani on pd-1/pd-l1 inhibitors in hematologic malignancies
Published 6 years ago • 87 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
0:57
dr. usmani on potential of checkpoint inhibitors in multiple myeloma
-
3:29
pd-l1/pd-1 pathway: a security checkpoint
-
1:15
dr. rizvi on pd-1 and pd-l1 inhibitors in lung cancer
-
0:59
dr. usmani on treatment of newly diagnosed myeloma
-
6:21
the emergence of pd-l1 inhibitors
-
50:26
pd-1/pd-l1 inhibitors: the first major wave of immuno-oncology | informa tokyo seminar
-
57:18
webinar - pd-1/pd-l1 inhibitors: the first wave of immuno-oncology
-
0:45
dr. usmani discusses management of early relapse in myeloma
-
57:38
pd-1 and pd-l1 checkpoint inhibitor pathway (webinar)
-
5:33
cancer immune checkpoint inhibitors
-
1:24:27
the renal pathology of check point inhibitors
-
2:03
dr. usmani on the dreamm trials in multiple myeloma
-
1:00
dr. mason on the reliability of the pd-l1 biomarker
-
0:45
dr. usmani discusses management of early relapse in myeloma
-
1:28
dr. usmani on minimal residual disease in multiple myeloma
-
2:07
immune checkpoint inhibitors, the next generation cancer therapy - creative biolabs
-
0:56
dr. usmani on combining daratumumab for multiple myeloma
-
1:11
dr. goodman on the role of pd-1 inhibitors in t-cell lymphomas
-
17:44
immune checkpoint inhibitors in lymphoma
-
0:55
dr. luke discusses pd-1 plus ido inhibitors in melanoma
-
1:06
dr. necchi on impact of pd-1 inhibition in bladder cancer
-
1:23
dr. scott gettinger on the pd-1 inhibitor bms-936558 in non-small cell lung cancer